Florida Stops Outbreak of Carbapenem-Resistant Enterobacteriaceae
In early 2011, the Centers for Disease Control and Prevention (CDC) sent a team of disease detectives to Florida to assist the state and a healthcare facility stop an outbreak of carbapenem-resistant Enterobacteriaceae, deadly pathogens that cause healthcare-associated infections.
CRE are a concern in long-term acute care hospitals, where patients who need to be on life-support for long periods of time receive care. They are resistant to almost all drugs, difficult to treat, and are associated with high death rates (up to 40 percent in some studies).  Read about Floridas success in stopping the spread of this public health threat by clicking HERE.Â
Â
If you want even more details about this outbreak, read the scientific paper in the October issue of the journal Infection Control and Hospital Epidemiology.
Â
For more information about how your facility can stop CRE, see CDCs CRE toolkit: http://www.cdc.gov/HAI/organisms/cre/index.html Â
Addressing Post-COVID Challenges: The Urgent Need for Enhanced Hospital Reporting Metrics
December 18th 2024Explore why CMS must expand COVID-19, influenza, and RSV reporting to include hospital-onset infections, health care worker cases, and ER trends, driving proactive prevention and patient safety.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.
